
Chetak Pharmaceuticals Pvt Ltd
Founded in 1984 and headquartered in Punjab, India.
Founded in 1984 and headquartered in Punjab, India.
+91-XXXXXXXXXX
U24232PB1984PTC005717
005717
Private Limited Indian Non-Government Company
30 Jan 1984
28 Sep 2017
31 Mar 2017
Unlisted
Roc Chandigarh
Name | Designation | Appointment Date | Status |
---|---|---|---|
Anandbir Brar ![]() | Director | 18-Jun-2015 | Current |
Indran Brar ![]() | Director | 22-Nov-1999 | Current |
Chetak Pharmaceuticals Pvt Ltd, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
In 2017, Chetak Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Anandbir Brar is a mutual person
Anandbir Brar and Indran Brar are mutual person
Anandbir Brar is a mutual person
Anandbir Brar is a mutual person
Indran Brar is a mutual person
Indran Brar is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Chetak Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Chetak Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chetak Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Chetak Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 28 Sep 2017 as per latest MCA records.
Chetak Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Chandigarh.
Anandbir Singh Brar was appointed as a Director was appointed as a Director on 18 Jun 2015 & has been associated with this company since 9 years 8 months .
Indran Brar was appointed as a Director was appointed as a Director on 22 Nov 1999 & has been associated with this company since 25 years 3 months .
Chetak Pharmaceuticals Pvt Ltd was registered on 30 Jan 1984 with Roc Chandigarh & aged 41 years 1 month as per MCA records.
Chetak Pharmaceuticals Pvt Ltd was incorporated on 30 Jan 1984.
The authorized share capital of Chetak Pharmaceuticals Pvt Ltd is ₹ 2.50 M and paid-up capital is ₹ 0.50 M.
Currently 2 directors are associated with Chetak Pharmaceuticals Pvt Ltd.
As per Ministry of Corporate Affairs (Mca), the registered address of Chetak Pharmaceuticals Pvt Ltd is C 51Industrial Areaphase Iii Sas Nagar India, Mohali, Punjab.
The corporate identification number (CIN) of Chetak Pharmaceuticals Pvt Ltd is U24232PB1984PTC005717 and the company number is 005717 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Chetak Pharmaceuticals Pvt Ltd was filed with the ROC on 31 Mar 2017.
Search company & director profiles for free and gain access to critical business data.
SS
MS